The two sector: before the end of October will be the national drug reimbursement list included in the new rural cooperative negotiation – Beijing, Beijing, October 14, according to the national health and Family Planning Commission website news, the national health and Family Planning Commission Office, general office of the Ministry of Finance recently issued a notice to require good negotiation in cooperation with the new type of rural drug reimbursement policy convergence. "Notice" clearly, the provinces have not yet adjusted, should be combined with local conditions, based on the implementation of price negotiations, and strive to be the national bargaining drugs into the NCMS reimbursement drug list before the end of October 2016. The national health and Family Planning Commission announced in May 20th the first batch of national drug price negotiations, including first-line treatment chronic hepatitis B drug tenofovir, non-small cell lung cancer targeted therapy of icotinib and gefitinib. Compared with the previous purchase price of public hospitals, 3 kinds of negotiating drug prices fell more than 50%. The "Circular", the establishment of national drug price negotiation mechanism is to deepen the medical and health system reform, improve the drug procurement mechanism, reduce the majority of patients medication burden and enhance people’s sense of identity and innovative initiatives to gain a sense of the. Do a good job in the negotiations with the new rural cooperative medical reimbursement policy convergence, so that people benefit in a timely manner, significant. The circular stressed that in accordance with the results of the national drug price negotiations in a timely manner to adjust the NCMS reimbursement of drugs directory. The provinces have not yet adjusted, according to the local economic development, the level of the NCMS funding, the ability of medical services, where the change of disease spectrum and the actual situation, based on the implementation of negotiations, and strive to national bargaining drugs into the NCMS reimbursement drug list before the end of October 2016, and submitted to the national health and Family Planning Commission grassroots division for the record. Fund expenditure pressure in the region, you can choose part of the species or from a serious illness insurance. "Notice" requirements, and effectively improve the accessibility and affordability of patients. All localities should do a good job in accordance with the relevant requirements of the country to negotiate the purchase of drugs, distribution, use and reimbursement and other work, the formation of policy forces. In the process of urban and rural residents basic medical insurance, unified reimbursement policy, the drug will be included in the scope of reimbursement negotiations. At the same time, do a good job of monitoring and evaluation, strengthen publicity and guidance, and actively respond to social concerns, and guide reasonable expectations, to create a good atmosphere. Annex: 2015 national drug price negotiation results of generic commodity production enterprise package price negotiations for Nuo Fuwei two imidacloprid furosemide esters of fumaric acid (Chinese) Wei Reed GSK Investment Co., 300mg× tablet bottle yuan icotinib Beida pharmaceutical Limited by Share Ltd Camry 125mg× 21. Yuanji gefitinib Iressa AstraZeneca 250mg× 10 yuan. Note: 1 price negotiations for the purchase price of public medical institutions connected with the current policy based on (including distribution costs); 2 2017 2016 – week period for purchasing.相关的主题文章: